[Multidisciplinary Assessment of Neurocognitive Disorders: Findings from a Day Hospital and the Influence of Educational Level].

Neurocognitive disorders represent a major public health challenge. We report the experience of a diagnostic day hospital that systematically integrates both a clinical pharmacist and a speech-language pathologist in a socioeconomically advantaged area. This retrospective study included patients undergoing their initial assessment at the day hospital. The primary objective was to describe their neurocognitive, pharmaceutical, and speech-language characteristics. As a secondary objective, we investigated differences according to educational level in pharmaceutical and speech-language assessments and recommendations. A total of 110 patients were included. Polypharmacy was identified in 55% of patients, and at least one pharmaceutical intervention was recommended in 75%. A high prevalence of language disorders was observed, leading to referral for speech therapy in 61% of cases. Compared with the general population consulting for neurocognitive disorders, our patients had a higher average sociocultural level. No significant differences according to educational level were observed in pharmaceutical or speech-language assessment outcomes. These findings highlight the potential value of integrating clinical pharmacy and speech-language pathology into multidisciplinary neurocognitive assessment pathways.